Beneficial treatment

A recent study described in the article 'Caregiver Responses to Nasoalveolar Molding and Early Cleft Care' in The Cleft Palate–Craniofacial Journal discusses how caregivers opting to treat their children with nasoalveolar molding (NAM) responded to the therapy. NAM is a nonsurgical treatment therapy designed to improve future surgical results, reduce the need for future surgeries and diminish scarring. The treatment requires surgical tape, an intraoral molding plate and nasal stents prior to lip surgery, beginning at approximately one month of age. The tapes need to be changed daily by the primary caregiver. Weekly or biweekly appliance adjustments by the cleft team orthodontist or pediatric dentist are also performed until approximately three to five months of age, at which time traditional surgery of the primary palate (lip) is performed.

The NIH-supported study revealed that although caregivers were initially anxious or overwhelmed at the thought of NAM, most experienced substantial benefits as a result of direct participation in their child’s cleft treatment. Many caregivers reported a stronger connection with the child, felt more empowered as parents, and found a support network with other NAM participants with which to share experiences.